This content is machine translated Atopic dermatitis Reduction of the exacerbation rate by strengthening the barrier function The evidence-based efficacy of two new preparations for the interval and acute treatment of atopic dermatitis is based on a targeted influence on the skin barrier. A special combination of…
View Post 4 min This content is machine translated New treatment options for psoriasis “Real life” interim balance: PASI 100 – realistic target Research into new biologics is helping to provide treatment alternatives for moderate to severe plaque psoriasis in the event of a lack of response or loss of efficacy [1]. That…
View Post 5 min This content is machine translated Psoriasis and cardiovascular comorbidities. Complex interaction structure: Implications for therapy Cardiovascular comorbidities in psoriasis may lead to a reciprocal influence of systemic therapies with implications for disease progression. Early detection and treatment are important factors in disease management
View Post 5 min This content is machine translated Rosacea Botulinum toxin against erythema The paradigm shift in diagnostic classification launched some time ago led to modifications in the treatment strategy. Nowadays, phenotype-specific symptom-oriented treatment is considered “best practice”. An interim review and outlook…
View Post 2 min This content is machine translated Actinic keratosis First S3 guideline provides certainty of action Actinic keratosis is already one of the most frequent clinical pictures in dermatological oncology. However, due to increasing life expectancy, a further increase in the number of affected patients can…
View Post 3 min This content is machine translated Guselkumab High response rate maintained over 4 years Recently presented long-term data from the VOYAGE 1 Phase III clinical trial demonstrate that 84% of patients continued to achieve PASI-90 at 204 weeks.
View Post 4 min This content is machine translated Oral mucosal diseases Interdisciplinary, diverse and complex Lesions of the mucosa may have localized causes, but may also be symptoms of systemic diseases. Thus, changes in the oral mucosa are also features of many skin diseases and…
View Post 3 min This content is machine translated Case Report Arthritis in a teenage football player A teenager presents to the hospital with urticaria, periodic fever, and suspected arthritis as well as myositis and myocarditis. In the search for the appropriate therapy, his condition initially worsens.
View Post 3 min This content is machine translated Risankizumab as a therapeutic option “Real life” interim balance: PASI 100 – realistic target Risankizumab has been approved in Switzerland since April 2019 for moderate to severe plaque psoriasis after unsuccessful therapy with conventional systemic treatment. The high and long-lasting efficacy with rapid response…
View Post 4 min This content is machine translated Atopic dermatitis Topical calcineurin inhibitors: Facts and myths Calcineurin inhibitors can be used in atopic dermatitis as monotherapy or combined with topical corticosteroids. Tacrolimus and pimecrolimus do not cause skin atrophy even with long-term use. Which treatment regimen…
View Post 10 min This content is machine translated Lymphomas The Sézary syndrome The nonspecific symptoms in the early stages lead to a significant diagnostic latency of these primary cutaneous T-cell lymphomas. Extracorporeal photopheresis and new targeted therapies are increasingly improving therapeutic success…
